National Virtual Biotechnology Laboratory Symposium


Harnessing the unique strengths of DOE to tackle the biotechnology challenges of COVID-19

What: A virtual symposium to highlight the impact the U.S. Department of Energy’s (DOE) National Virtual Biotechnology Laboratory (NVBL) has had, utilizing the unique capabilities of the DOE to tackle the science and technology challenges associated with COVID-19, and to discuss areas in which the NVBL can have impact in the future. The event is aimed at the S&T community, media and the general public. All attendees must register (including press, link below).

Date: Wednesday, Oct. 28

Time: 11:30 a.m.-3:30 p.m. Eastern Time

Where: Zoom virtual symposium. Registration link here.

Details: With perspectives from Chris Fall, director, Office of Science, DOE, and William Bookless, principal deputy administrator of the National Nuclear Security Administration, the event will feature presentations from lead investigators from across the DOE complex who will present progress on:

  • Epidemiological modeling
  • Therapeutics
  • Testing
  • Understanding transport of the virus
  • Solving issues around supply chain challenges

In addition, keynote speakers from outside the NVBL will discuss the upcoming science and technology needs in computing, testing and surveillance and vaccines.


  • NVBL co-leads Michelle Buchanan, Oak Ridge National Laboratory, and Stephen Streiffer, Argonne National Laboratory, “Overview of Science & Technology Challenges for COVID”
  • Bruce Tromberg, director, National Institute of Biomedical Imaging & Bioengineering, National Institutes of Health, “Future S&T Needs: Future of Testing & Surveillance”
  • Jim Brase, deputy associate director for Computing, Lawrence Livermore National Laboratory, “Future S&T Needs: AI/ML and Computing”
  • Greg Burel, president, Hamilton Grace, LLC, “Future S&T Needs: Vaccines”
  • Harriet Kung, deputy director for Science, DOE Office of Science, “Closing Remarks”

Full agenda available on the NVBL Symposium website.

/Public Release. This material comes from the originating organization and may be of a point-in-time nature, edited for clarity, style and length. View in full here.